Dr. Vincent Rajkimar provides an update on a trial of Revlimid with dexamethasone in multiple myeloma at the 2007 ASCO meeting. This trial concluded that lower doses of dex produced superior results. For more information, contact the International Myeloma Foundation, [ Ссылка ], theimf@myeloma.org, 800-452-2873 or 818-487-7455

свернуть